Artia Global Partners LP Dyne Therapeutics, Inc. Transaction History
Artia Global Partners LP
- $498 Billion
- Q1 2024
A detailed history of Artia Global Partners LP transactions in Dyne Therapeutics, Inc. stock. As of the latest transaction made, Artia Global Partners LP holds 119,488 shares of DYN stock, worth $4.14 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
119,488Holding current value
$4.14 Million% of portfolio
0.68%Shares
1 transactions
Others Institutions Holding DYN
# of Institutions
176Shares Held
87.1MCall Options Held
130KPut Options Held
209K-
Atlas Venture Life Science Advisors, LLC8.02MShares$278 Million28.49% of portfolio
-
Fcpm Iii Services B.V. Naarden, P77.85MShares$272 Million31.49% of portfolio
-
Black Rock Inc. New York, NY5.39MShares$187 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.56MShares$158 Million4.27% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il4.25MShares$147 Million0.02% of portfolio
About Dyne Therapeutics, Inc.
- Ticker DYN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,765,400
- Market Cap $1.79B
- Description
- Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and...